...al. Nat. Commun. ; published online Aug. 22, 2019 doi:10.1038/s41467-019-11732-6 CONTACT: Michael E. Berens, The Translational Genomics Research Institute...
...charles-brenner@uiowa.edu CONTACT: Ranjit S. Bindra, Yale University, New Haven, Conn. email: ranjit.bindra@yale.edu Claire Quang Yale University University of Iowa Translational Genomics Research Institute Nicotinamide...

...email: mmurtaza@tgen.org CONTACT: Muhammed Murtaza, Translational Genomics Research Institute, Phoenix, Ariz.; Mayo Clinic, Scottsdale, Ariz. email: mmurtaza@tgen.org Hongjiang Li Mayo Clinic Translational Genomics Research Institute Breast...

...1 (TACC1) oncogenic fusion protein and activating mutation as a targetable marker of high-risk cancers Translational Genomics Research Institute...

...There is no specified treatment regimen after first relapse. MMRF and its collaborators, including the Translational Genomics Research Institute...
...York, N.Y. Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Tokyo, Japan Translational Genomics Research Institute...
...FGFR3 had been previously identified by MMRF collaborators as being frequently mutated in MM patients. Translational Genomics Research Institute...

...OHSU formed a subgroup with labs from the University of California San Diego and the Translational Genomics Research Institute...
...NIH), Bethesda, Md. Ohio State University, Columbus, Ohio Oregon Health & Science University, Portland, Ore. Translational Genomics Research Institute...
...of California San Diego NCATS $2,161,068 exRNA Signatures Predict Outcomes After Brain Injury Kendall Jensen Translational Genomics Research Institute...

...et al. Nat. Genet.; published online March 23, 2014; doi:10.1038/ng.2928 Contact: Jeffrey M. Trent, The Translational Genomics Research Institute...

...CEO and chairman of Cylene Pharmaceuticals Inc. ; and Daniel Von Hoff, physician-in-chief at the Translational Genomics Research Institute...

...a collaboration between MMRF, the Broad Institute of MIT and Harvard (Cambridge, Mass.) and the Translational Genomics Research Institute...

...The Translational Drug Development (TD2) subsidiary of the not-for-profit Translational Genomics Research Institute (Phoenix, Ariz.) began an open-label, dose-escalation...